Рет қаралды 370
SCID is a life-limiting IEI and remains undiagnosed in a substantial proportion of affected newborns. Successful treatment critically depends on early and infections-free diagnosis. SCID newborn screening has become reality in several countries and even more countries are about to implement it. Germany has started nationwide SCID screening in August 2019 and up-to-date more than 2M newborns have been screened.
In this webinar, Fabian Hauck presented the German screening algorithm, confirmatory diagnostics, the SCID-screening-network, and clinical, genetic, and epidemiological patient data. Unmet needs now emerging were also discussed.
Speaker:
Fabian Hauck, MD, PhD
Assistant Professor, Head Pediatric Immunology and Rheumatology
Pediatrics / Pediatric Hematology and Oncology / Immunology (DGfI)
LMU Klinikum, Munich
Chairs:
Martine Pergent, IPOPI
Alexandre Belot, Head of Pediatric Rheumatology Unit, CHU Lyon
Please check ern-rita.org/webinars for all recordings and information on future webinars.